AGI Therapeutics, Aravis Therapeutics deal

Aravis began its tender offer to acquire AGI Therapeutics for €10.7 million ($13.6 million) in cash. AGI's board unanimously recommended that AGI shareholders accept the offer. Aravis said the acquisition will provide a management team with experience in repurposing drugs for unmet medical needs. Altiva Capital LLC, a private equity firm, will provide Aravis with cash for the acquisition. Goodbody Corp. Finance advised Aravis while Davy Corp. Finance advised AGI. Beauchamps Solicitors is AGI's legal advisor. A&L Goodbody and Burke, Warren, MacKay & Serritella P.C. are Aravis' Irish and U.S. legal advisors, respectively. Aravis is a wholly owned subsidiary of Altiva. ...